Safety and Efficacy of ActiGraft Treatment in Wound Care in Medical Centers
ConditionCutaneous Wounds
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorRedDress Ltd.
About this trial
Multicenter observational study to explore the efficacy of ActiGraft in the treatment of exuding cutaneous wounds in real-life usage.
Eligibility criteria
Qualifiers
Subject is ≥18 years of age
Subject has an exuding cutaneous wound
Subject agrees to the use of his health data, including photos of his wound in analysis and publications
Subject/LAR must be able to read and understand English and/or Spanish
Disqualifiers
Subject/LAR is unable to read and understand English or Spanish.
Trial design
Treatments tested in this trial
- ActiGraft
Treatment groups
500 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov